Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us

J Natl Cancer Inst. 2002 Jun 19;94(12):883-93. doi: 10.1093/jnci/94.12.883.

Authors

Lynn Hlatky¹, Philip Hahnfeldt, Judah Folkman

Affiliation

¹ Dana-Farber Cancer Institute and the Department of Radiation Oncology, Harvard Medical School, Boston, MA 02115, USA. Lynn_Hlatky@dfci.harvard.edu

PMID: 12072542
DOI: 10.1093/jnci/94.12.883

No abstract available

Publication types

Review

MeSH terms

Angiogenesis Inhibitors / therapeutic use*
Humans
Microcirculation / drug effects
Microcirculation / pathology*
Neoplasms / blood supply*
Neoplasms / drug therapy*
Neovascularization, Pathologic / prevention & control*

Substances

Angiogenesis Inhibitors